LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Holiday book sale: Save up to 30% on print and eBooks. No promo code needed.
Save up to 30% on print and eBooks.
1st Edition - January 26, 2019
Editor: Prashant Kesharwani
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
PrefacePrashant Kesharwani1. Introduction: An Overview of the anatomy and physiology of the lungShadab Md2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug ResistanceChitra Thakur3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancerBapi Gorain4. Polymeric nanoparticles based drug delivery for lung cancerLipika Ray5. Solid lipid nanoparticles based drug delivery for lung cancerAhmed Elzoghby6. Liposomes and niosomes based drug delivery for lung cancerPaulina Skupin-Mrugalska7. Dendrimers based drug delivery for lung cancerPrashant Kesharwani8. Micelles based drug delivery for lung cancerKhaled Greish9. Nanoemulsions based drug delivery for lung cancerHira Choudhury10. Nanomedicine-based inhalation treatments for lung cancerRémi Rosière11. Towards development of novel diagnostic nano-imaging platform for lung cancerZahid Hussain12. Hydrogel based drug delivery for lung cancerVijay Mishra13. Quantum dots based drug delivery for lung cancerVijay Mishra
PK
Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He is a recipient of many research grants from various funding bodies. He is also a receipt of several internationally acclaimed awards such as the most prestigious “Ramanujan Fellowship Award” from the Science and Engineering Research Board, Government of India. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of wider community. He actively participates in outreach and scientific dissemination for the service of the wider community.